InnovAge Holding Corp. (NASDAQ:INNV) Shares Purchased by Barclays PLC

Barclays PLC lifted its stake in InnovAge Holding Corp. (NASDAQ:INNV) by 289.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,614 shares of the company’s stock after acquiring an additional 19,029 shares during the period. Barclays PLC’s holdings in InnovAge were worth $154,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. State Street Corp lifted its position in InnovAge by 1.2% in the third quarter. State Street Corp now owns 344,905 shares of the company’s stock worth $2,069,000 after purchasing an additional 4,218 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of InnovAge by 3.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 165,531 shares of the company’s stock valued at $993,000 after buying an additional 6,153 shares during the period. Renaissance Technologies LLC boosted its stake in InnovAge by 3.1% during the second quarter. Renaissance Technologies LLC now owns 136,400 shares of the company’s stock valued at $677,000 after buying an additional 4,100 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in InnovAge by 27.1% during the second quarter. Bank of New York Mellon Corp now owns 58,322 shares of the company’s stock worth $289,000 after acquiring an additional 12,448 shares during the period. Finally, Rhumbline Advisers raised its position in InnovAge by 7.0% in the second quarter. Rhumbline Advisers now owns 27,503 shares of the company’s stock worth $136,000 after acquiring an additional 1,793 shares in the last quarter. 12.26% of the stock is currently owned by institutional investors.

InnovAge Trading Down 3.1 %

Shares of NASDAQ INNV opened at $3.69 on Wednesday. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.27. InnovAge Holding Corp. has a 12 month low of $3.52 and a 12 month high of $6.69. The company has a market cap of $499.83 million, a price-to-earnings ratio of -30.75 and a beta of 0.37. The business has a fifty day simple moving average of $4.77 and a 200-day simple moving average of $5.47.

InnovAge (NASDAQ:INNV) last posted its quarterly earnings data on Tuesday, November 5th. The company reported ($0.04) EPS for the quarter, meeting analysts’ consensus estimates of ($0.04). The company had revenue of $205.14 million during the quarter, compared to analyst estimates of $203.35 million. InnovAge had a negative net margin of 2.03% and a negative return on equity of 5.68%. During the same period in the prior year, the firm earned ($0.08) earnings per share. Sell-side analysts predict that InnovAge Holding Corp. will post -0.06 EPS for the current year.

Analyst Upgrades and Downgrades

INNV has been the subject of several research reports. KeyCorp began coverage on shares of InnovAge in a research report on Friday, October 11th. They set a “sector weight” rating for the company. JPMorgan Chase & Co. restated an “underweight” rating and set a $5.00 target price on shares of InnovAge in a report on Tuesday, December 17th.

InnovAge Profile

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.